ADVERTISEMENTREMOVE AD

Indian Firm Panacea Partners With US Company to Make COVID Vaccine

Indian Firm Panacea Partners With US Company to Make COVID Vaccine

Published
Fit
1 min read
story-hero-img
i
Aa
Aa
Small
Aa
Medium
Aa
Large
Hindi Female
ADVERTISEMENTREMOVE AD

Indian firm Panacea Biotec Ltd. and US-based Refana Inc. will be joining hands to produce and distribute a potential vaccine for COVID-19, according to a Livemint report.

Panacea Biotec will be liable for product development and commercial manufacturing of an inactivated virus-based vaccine, the Indian firm announced in an exchange filing.

The collaborative aim is to create more than 500 million doses of the vaccine, along with 40 million doses awaited to be available by next year, Livemint quoted Jain.

Clinical development would be undertaken by the joint venture and regulatory submissions will be made globally. Panacea Biotec and Refana will undertake sales and distribution of the vaccine after the regulatory approval in their own territories.

As of now, about 130 vaccines are under development stages, out of which 10 are under clinical trials.

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

0

Read Latest News and Breaking News at The Quint, browse for more from fit

Topics:  Quint Fit 

Speaking truth to power requires allies like you.
Become a Member
3 months
12 months
12 months
Check Member Benefits
Read More
×
×